Suppr超能文献

2型糖尿病患者健康饮食习惯的数字支持:初级保健中的一项随机临床试验方案(HAPPY试验)

Digital Support for Healthier Eating Habits Among Patients With Type 2 Diabetes: Protocol for a Randomized Clinical Trial Within Primary Care (HAPPY Trial).

作者信息

Trolle Lagerros Ylva, Dahlgren Anna, Sjöblom Linnea, Bonn Stephanie E

机构信息

Clinical Epidemiology Division, Department of Medicine, Solna, Karolinska Institutet, Solna, Sweden.

Center for Obesity, Academic Specialist Center, Stockholm Health Services, Stockholm, Sweden.

出版信息

JMIR Res Protoc. 2020 Nov 16;9(11):e24422. doi: 10.2196/24422.

Abstract

BACKGROUND

Despite the large impact that dietary habits have in the management of diabetes, few tools for supporting healthy eating habits are available for persons with diabetes.

OBJECTIVE

The aim of this randomized clinical trial is to evaluate the effect of a 12-week, mobile health (mHealth), app-based intervention promoting healthy eating habits among patients with type 2 diabetes.

METHODS

The HAPPY (Healthy eating using APP technologY) trial is a randomized clinical trial with two arms aiming to include 200 patients, 18 years of age or older, with type 2 diabetes. Both women and men are eligible for inclusion. Study participants are randomized 1:1 to an intervention group, where they are instructed to use a smartphone app promoting healthy eating, or to a control group, where they receive standard primary care only, for a period of 12 weeks. Each week a new topic (eg, vegetable intake) is introduced via the app. After an introduction text, the user is given a topic-related activity to perform (eg, eat one additional serving of vegetables per day during that week). The app records daily progress and sends automatic reminders or feedback to the user. Dietary intake, body composition, clinical variables, and biomarkers are measured at baseline and at 3- and 6-month follow-ups. An extensive web-based questionnaire comprising several validated questionnaires assessing a number of lifestyle factors is distributed via email at baseline and at 3-, 6-, and 12-month follow-ups; lifestyle factors include, for example, sleep, physical activity, eating behavior, and health-related quality of life. The effect of the intervention on dietary intake (primary outcome) and on glycated hemoglobin and blood lipid levels, body composition, blood pressure, other lifestyle factors, and overall health (secondary outcomes) will be assessed.

RESULTS

Data collection is ongoing. Recruitment of participants started in January 2019. Findings from the study are expected to be published by the end of 2021.

CONCLUSIONS

Technology development provides new ways to promote and support long-term adherence to healthier eating habits. mHealth-based approaches allow for real-time interaction and the delivery of an intervention at any time. Further, focusing on overall diet allows the user to apply new knowledge to current eating patterns, creating an individualized approach. In this study, we evaluate the effect of using a new smartphone app promoting healthy eating habits on dietary intake, clinical markers, and lifestyle factors among patients with type 2 diabetes.

TRIAL REGISTRATION

ClinicalTrials.gov NCT03784612; https://clinicaltrials.gov/ct2/show/NCT03784612.

INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID): DERR1-10.2196/24422.

摘要

背景

尽管饮食习惯对糖尿病管理有很大影响,但针对糖尿病患者的支持健康饮食习惯的工具却很少。

目的

本随机临床试验的目的是评估一项为期12周的基于移动健康(mHealth)应用程序的干预措施对2型糖尿病患者促进健康饮食习惯的效果。

方法

HAPPY(使用APP技术促进健康饮食)试验是一项随机临床试验,分为两组,旨在纳入200名18岁及以上的2型糖尿病患者。男女均符合纳入条件。研究参与者按1:1随机分为干预组和对照组,干预组被指导使用一款促进健康饮食的智能手机应用程序,对照组仅接受标准初级护理,为期12周。该应用程序每周介绍一个新主题(如蔬菜摄入量)。在一段介绍文字后,会给用户一项与主题相关的活动去完成(如在那一周每天多吃一份蔬菜)。该应用程序会记录每日进展,并向用户发送自动提醒或反馈。在基线以及3个月和6个月随访时测量饮食摄入量、身体成分、临床变量和生物标志物。在基线以及3个月、6个月和12个月随访时,通过电子邮件分发一份广泛的基于网络的问卷,其中包括几份经过验证的问卷,用于评估一些生活方式因素;生活方式因素包括例如睡眠、身体活动、饮食行为和与健康相关的生活质量。将评估干预措施对饮食摄入量(主要结局)以及糖化血红蛋白和血脂水平、身体成分、血压、其他生活方式因素和整体健康(次要结局)的影响。

结果

数据收集正在进行中。参与者招募于2019年1月开始。该研究的结果预计将于2021年底发表。

结论

技术发展为促进和支持长期坚持更健康的饮食习惯提供了新方法。基于移动健康的方法允许实时互动,并能在任何时间提供干预。此外,关注整体饮食能让用户将新知识应用于当前的饮食模式,创造一种个性化的方法。在本研究中,我们评估使用一款促进健康饮食习惯的新智能手机应用程序对2型糖尿病患者的饮食摄入量、临床指标和生活方式因素的影响。

试验注册

ClinicalTrials.gov NCT03784612;https://clinicaltrials.gov/ct2/show/NCT03784612。

国际注册报告识别码(IRRID):DERR1-10.2196/24422。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3144/7704281/3366afe6920b/resprot_v9i11e24422_fig1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验